Exercise- and resveratrol-mediated alterations in adipose tissue metabolism

Applied Physiology, Nutrition and Metabolism

Volumn 39, Issue 2, 2014, Pages 109-116

  Wright, David C ^a  

^a UNIVERSITY OF GUELPH   (Canada)

Author keywords

Adipose; AMPK; Catecholamines; Exercise; IL 6; Mitochondria; Reesterification; Resveratrol; Rodent

Indexed keywords

2,4 THIAZOLIDINEDIONE DERIVATIVE; GLUCOSE; RESVERATROL; STILBENE DERIVATIVE;

ADIPOSE TISSUE; ANIMAL; DRUG EFFECTS; EXERCISE; GENE EXPRESSION REGULATION; HOMEOSTASIS; HUMAN; METABOLISM; MITOCHONDRION; PHYSIOLOGY;

ADIPOSE TISSUE; ANIMALS; EXERCISE; GENE EXPRESSION REGULATION; GLUCOSE; HOMEOSTASIS; HUMANS; MITOCHONDRIA; STILBENES; THIAZOLIDINEDIONES;

EID: 84893373043     PISSN: 17155312     EISSN: 17155320     Source Type: Journal    
DOI: 10.1139/apnm-2013-0316     Document Type: Review

References (121)

1. Ahmadian, M., Duncan, R. E., Varady, K. A., Frasson, D., Hellerstein, M. K., Birkenfeld, A. L., et al. 2009. Adipose overexpression of desnutrin promotes fatty acid use and attenuates diet-induced obesity. Diabetes, 58: 855-866. doi:10.2337/db08-1644. PMID:19136649.
2. Ahmadian, M., Suh, J. M., Hah, N., Liddle, C., Atkins, A. R., Downes, M., and Evans, R. M. 2013. PPARgamma signaling and metabolism: the good, the bad and the future. Nat. Med. 19: 557-566. doi:10.1038/nm.3159. PMID:23652116.
3. Aronoff, S., Rosenblatt, S., Braithwaite, S., Egan, J. W., Mathisen, A. L., and Schneider, R. L. 2000. Pioglitazone hydrochloride monotherapy improves glycemic control in the treatment of patients with type 2 diabetes: a 6-month randomized placebo-controlled dose-response study. The Pioglitazone 001 Study Group. Diabetes Care, 23: 1605-1611. doi:10.2337/diacare.23.11.1605. PMID:11092281.
4. Beaudoin, M. S., Snook, L. A., Arkell, A. M., Simpson, J. A., Holloway, G. P., and Wright, D. C. 2013. Resveratrol supplementation improves white adipose tissue function in a depot-specific manner in Zucker diabetic fatty (ZDF) rats. Am. J. Physiol. Regul. Integr. Comp. Physiol. 305 (5): R542-R551. doi:10.1152/ajpregu.00200.2013. PMID:23824959.
5. Bogacka, I., Xie, H., Bray, G. A., and Smith, S. R. 2005. Pioglitazone induces mitochondrial biogenesis in human subcutaneous adipose tissue in vivo. Diabetes, 54: 1392-1399. doi:10.2337/diabetes.54.5.1392. PMID:15855325.
6. Bostrom, P., Wu, J., Jedrychowski, M. P., Korde, A., Ye, L., Lo, J. C., et al. 2012. A PGC1-α-dependent myokine that drives brown-fat-like development of white fat and thermogenesis. Nature, 481: 463-468. doi:10.1038/nature10777. PMID:22237023.
7. Brooks, B., Arch, J. R., and Newsholme, E. A. 1982. Effects of hormones on the rate of the triacylglycerol/fatty acid substrate cycle in adipocytes and epididymal fat pads. FEBS Lett. 146: 327-330. doi:10.1016/0014-5793(82)80945-9. PMID:6128259.
8. Bruckbauer, A., Zemel, M. B., Thorpe, T., Akula, M. R., Stuckey, A. C., Osborne, D., et al. 2012. Synergistic effects of leucine and resveratrol on insulin sensitivity and fat metabolism in adipocytes and mice. Nutr. Metab. (Lond.), 9: 77. doi:10.1186/1743-7075-9-77. PMID:22913271.
9. Cadoudal, T., Blouin, J. M., Collinet, M., Fouque, F., Tan, G. D., Loizon, E., et al. 2007. Acute and selective regulation of glyceroneogenesis and cytosolic phosphoenolpyruvate carboxykinase in adipose tissue by thiazolidinediones in type 2 diabetes. Diabetologia, 50: 666-675. doi:10.1007/s00125-006-0560-5. PMID:17242918.
10. Cadoudal, T., Distel, E., Durant, S., Fouque, F., Blouin, J. M., Collinet, M., et al. 2008. Pyruvate dehydrogenase kinase 4: regulation by thiazolidinediones and implication in glyceroneogenesis in adipose tissue. Diabetes, 57: 2272-2279. doi:10.2337/db08-0477. PMID:18519799.
11. Camera, D. M., Anderson, M. J., Hawley, J. A., and Carey, A. L. 2010. Short-term endurance training does not alter the oxidative capacity of human subcutaneous adipose tissue. Eur. J. Appl. Physiol. 109: 307-316. doi:10.1007/s00421-010-1356-3. PMID:20084391.
12. + metabolism and SIRT1 activity. Nature, 458: 1056-1060. doi:10.1038/nature07813. PMID:19262508.
13. Canto, C., Jiang, L. Q., Deshmukh, A. S., Mataki, C., Coste, A., Lagouge, M., et al. 2010. Interdependence of AMPK and SIRT1 for metabolic adaptation to fasting and exercise in skeletal muscle. Cell Metab. 11: 213-219. doi:10.1016/j.cmet.2010.02.006. PMID:20197054.
14. Carey, A. L., Steinberg, G. R., Macaulay, S. L., Thomas, W. G., Holmes, A. G., Ramm, G., et al. 2006. Interleukin-6 increases insulin-stimulated glucose disposal in humans and glucose uptake and fatty acid oxidation in vitro via AMP-activated protein kinase. Diabetes, 55: 2688-2697. doi:10.2337/db05-1404. PMID:17003332.
15. Cartier, A., Lemieux, I., Almeras, N., Tremblay, A., Bergeron, J., and Despres, J. P. 2008. Visceral obesity and plasma glucose-insulin homeostasis: contributions of interleukin-6 and tumor necrosis factor-alpha in men. J. Clin. Endocrinol. Metab. 93: 1931-1938. doi:10.1210/jc.2007-2191. PMID:18319319.
16. Chabowski, A., Zendzian-Piotrowska, M., Nawrocki, A., and Gorski, J. 2012. Not only accumulation, but also saturation status of intramuscular lipids is significantly affected by PPARγ activation. Acta Physiol. (Oxf.), 205: 145-158. doi:10.1111/j.1748-1716.2011.02380.x. PMID:22023892.
17. Chao, L., Marcus-Samuels, B., Mason, M. M., Moitra, J., Vinson, C., Arioglu, E., et al. 2000. Adipose tissue is required for the antidiabetic, but not for the hypolipidemic, effect of thiazolidinediones. J. Clin. Invest. 106: 1221-1228. doi:10.1172/JCI11245. PMID:11086023.
18. Chen, C. J., Yu, W., Fu, Y. C., Wang, X., Li, J. L., and Wang, W. 2009. Resveratrol protects cardiomyocytes from hypoxia-induced apoptosis through the SIRT1-FoxO1 pathway. Biochem. Biophys. Res. Commun. 378: 389-393. doi:10.1016/j.bbrc.2008.11.110. PMID:19059213.
19. Choo, H. J., Kim, J. H., Kwon, O. B., Lee, C. S., Mun, J. Y., Han, S. S., et al. 2006. Mitochondria are impaired in the adipocytes of type 2 diabetic mice. Diabetologia, 49: 784-791. doi:10.1007/s00125-006-0170-2. PMID:16501941.
20. Do, G. M., Jung, U. J., Park, H. J., Kwon, E. Y., Jeon, S. M., McGregor, R. A., and Choi, M. S. 2012. Resveratrol ameliorates diabetes-related metabolic changes via activation of AMP-activated protein kinase and its downstream targets in db/db mice. Mol. Nutr. Food Res. 56: 1282-1291. doi:10.1002/mnfr.201200067. PMID:22715031.
21. Dolinsky, V. W., Rueda-Clausen, C. F., Morton, J. S., Davidge, S. T., and Dyck, J. R. 2011. Continued postnatal administration of resveratrol prevents dietinduced metabolic syndrome in rat offspring born growth restricted. Diabetes, 60: 2274-2284. doi:10.2337/db11-0374. PMID:21810598.
22. Dolinsky, V. W., Jones, K. E., Sidhu, R. S., Haykowsky, M., Czubryt, M. P., Gordon, T., and Dyck, J. R. 2012. Improvements in skeletal muscle strength and cardiac function induced by resveratrol during exercise training contribute to enhanced exercise performance in rats. J. Physiol. 590: 2783-2799. doi:10.1113/jphysiol.2012.230490. PMID:22473781.
23. Festuccia, W. T., Laplante, M., Berthiaume, M., Gelinas, Y., and Deshaies, Y. 2006. PPARgamma agonism increases rat adipose tissue lipolysis, expression of glyceride lipases, and the response of lipolysis to hormonal control. Diabetologia, 49: 2427-2436. doi:10.1007/s00125-006-0336-y. PMID:16906479.
24. Franckhauser, S., Munoz, S., Pujol, A., Casellas, A., Riu, E., Otaegui, P., Su, B., and Bosch, F. 2002. Increased fatty acid re-esterification by PEPCK overexpression in adipose tissue leads to obesity without insulin resistance. Diabetes, 51: 624-630. doi:10.2337/diabetes.51.3.624. PMID:11872659.
25. Gauthier, M. S., Miyoshi, H., Souza, S. C., Cacicedo, J. M., Saha, A. K., Greenberg, A. S., and Ruderman, N. B. 2008. AMP-activated protein kinase is activated as a consequence of lipolysis in the adipocyte: potential mechanism and physiological relevance. J. Biol. Chem. 283: 16514-16524. doi:10.1074/jbc.M708177200. PMID:18390901.
26. Haemmerle, G., Lass, A., Zimmermann, R., Gorkiewicz, G., Meyer, C., Rozman, J., et al. 2006. Defective lipolysis and altered energy metabolism in mice lacking adipose triglyceride lipase. Science, 312: 734-737. doi:10.1126/science.1123965. PMID:16675698.
27. Hakansson, J., Eliasson, B., Smith, U., and Enerback, S. 2011. Adipocyte mitochondrial genes and the forkhead factor FOXC2 are decreased in type 2 diabetes patients and normalized in response to rosiglitazone. Diabetol. Metab. Syndr. 3: 32. doi:10.1186/1758-5996-3-32. PMID:22098677.
28. Hammarstedt, A., Sopasakis, V. R., Gogg, S., Jansson, P. A., and Smith, U. 2005. Improved insulin sensitivity and adipose tissue dysregulation after shortterm treatment with pioglitazone in non-diabetic, insulin-resistant subjects. Diabetologia, 48: 96-104. doi:10.1007/s00125-004-1612-3. PMID:15624096.
29. Hanson, R. W., and Reshef, L. 2003. Glyceroneogenesis revisited. Biochimie, 85: 1199-1205. doi:10.1016/j.biochi.2003.10.022. PMID:14739071.
30. Hashimoto, T., Sato, K., and Iemitsu, M. 2013. Exercise-inducible factors to activate lipolysis in adipocytes. J. Appl. Physiol. 115 (2): 260-267. doi:10.1152/japplphysiol.00427.2013. PMID:23681914.
31. Holloszy, J. O. 1967. Biochemical adaptations in muscle. Effects of exercise on mitochondrial oxygen uptake and respiratory enzyme activity in skeletal muscle. J. Biol. Chem. 242: 2278-2282. PMID:4290225.
32. ++. J. Gen. Physiol. 50: 551-562. doi:10.1085/jgp.50.3.551. PMID:11526846.
33. Holloszy, J. O., and Narahara, H. T. 1967b. Nitrate ions: Potentiation of increased permeability to sugar associated with muscle contraction. Science, 155: 573-575. doi:10.1126/science.155.3762.573. PMID:6015873.
34. Hou, X., Xu, S., Maitland-Toolan, K. A., Sato, K., Jiang, B., Ido, Y., et al. 2008. SIRT1 regulates hepatocyte lipid metabolism through activating AMP-activated protein kinase. J. Biol. Chem. 283: 20015-20026. doi:10.1074/jbc.M802187200. PMID:18482975.
35. Howitz, K. T., Bitterman, K. J., Cohen, H. Y., Lamming, D. W., Lavu, S., Wood, J. G., et al. 2003. Small molecule activators of sirtuins extend Saccharomyces cerevisiae lifespan. Nature, 425: 191-196. doi:10.1038/nature01960. PMID:12939617.
36. Hu, Y., Liu, J., Wang, J., and Liu, Q. 2010. The controversial links among calorie restriction, SIRT1, and resveratrol. Free Radic. Biol. Med. 51: 250-256. doi:10.1016/j.freeradbiomed.2011.04.034. PMID:21569839.
37. Jager, S., Handschin, C., St-Pierre, J., and Spiegelman, B. M. 2007. AMP-activated protein kinase (AMPK) action in skeletal muscle via direct phosphorylation of PGC-1α. Proc. Natl. Acad. Sci. U. S. A. 104: 12017-12022. doi:10.1073/pnas.0705070104. PMID:17609368.
38. Ji, C., Chen, X., Gao, C., Jiao, L., Wang, J., Xu, G., Fu, H., Guo, X., and Zhao, Y. 2011. IL-6 induces lipolysis and mitochondrial dysfunction, but does not affect insulin-mediated glucose transport in 3T3-L1 adipocytes. J. Bioenerg. Biomembr. 43 (4): 367-375. doi:10.1007/s10863-011-9361-8. PMID:21732177.
39. Kang, W., Hong, H. J., Guan, J., Kim, D. G., Yang, E. J., Koh, G., et al. 2011. Resveratrol improves insulin signaling in a tissue-specific manner under insulinresistant conditions only: in vitro and in vivo experiments in rodents. Metabolism, 61: 424-433. doi:10.1016/j.metabol.2011.08.003. PMID:21945106.
40. Keller, P., Keller, C., Carey, A. L., Jauffred, S., Fischer, C. P., Steensberg, A., and Pedersen, B. K. 2003. Interleukin-6 production by contracting human skeletal muscle: autocrine regulation by IL-6. Biochem. Biophys. Res. Commun. 310: 550-554. doi:10.1016/j.bbrc.2003.09.048. PMID:14521945.
41. Kelly, M., Keller, C., Avilucea, P. R., Keller, P., Luo, Z., Xiang, X., et al. 2004. AMPK activity is diminished in tissues of IL-6 knockout mice: the effect of exercise. Biochem. Biophys. Res. Commun. 320: 449-454. doi:10.1016/j.bbrc.2004.05.188. PMID:15219849.
42. Kleiner, S., Mepani, R. J., Laznik, D., Ye, L., Jurczak, M. J., Jornayvaz, F. R., et al. 2012. Development of insulin resistance in mice lacking PGC-1alpha in adipose tissues. Proc. Natl. Acad. Sci. U. S. A. 109: 9635-9640. doi:10.1073/pnas.1207287109. PMID:22645355.
43. Koh, E. H., Park, J. Y., Park, H. S., Jeon, M. J., Ryu, J. W., Kim, M., et al. 2007. Essential role of mitochondrial function in adiponectin synthesis in adipocytes. Diabetes, 56: 2973-2981. doi:10.2337/db07-0510. PMID:17827403.
44. Kubota, N., Terauchi, Y., Kubota, T., Kumagai, H., Itoh, S., Satoh, H., et al. 2006. Pioglitazone ameliorates insulin resistance and diabetes by both adiponectindependent and-independent pathways. J. Biol. Chem. 281: 8748-8755. doi:10.1074/jbc.M505649200. PMID:16431926.
45. Kuhlmann, J., Neumann-Haefelin, C., Belz, U., Kalisch, J., Juretschke, H. P., Stein, M., et al. 2003. Intramyocellular lipid and insulin resistance: a longitudinal in vivo 1H-spectroscopic study in Zucker diabetic fatty rats. Diabetes, 52: 138-144. doi:10.2337/diabetes.52.1.138. PMID:12502504.
46. Lagouge, M., Argmann, C., Gerhart-Hines, Z., Meziane, H., Lerin, C., Daussin, F., et al. 2006. Resveratrol improves mitochondrial function and protects against metabolic disease by activating SIRT1 and PGC-1α. Cell, 127: 1109-1122. doi:10.1016/j.cell.2006.11.013. PMID:17112576.
47. Lasa, A., Churruca, I., Eseberri, I., Andres-Lacueva, C., and Portillo, M. P. 2012a. Delipidating effect of resveratrol metabolites in 3T3-L1 adipocytes. Mol. Nutr. Food Res. 56: 1559-1568. doi:10.1002/mnfr.201100772. PMID:22945685.
48. Lasa, A., Schweiger, M., Kotzbeck, P., Churruca, I., Simon, E., Zechner, R., and Portillo, M. P. 2012b. Resveratrol regulates lipolysis via adipose triglyceride lipase. J. Nutr. Biochem. 23: 379-384. doi:10.1016/j.jnutbio.2010.12.014. PMID:21543206.
49. Lee, J. H., Song, M. Y., Song, E. K., Kim, E. K., Moon, W. S., Han, M. K., et al. 2009. Overexpression of SIRT1 protects pancreatic β-cells against cytokine toxicity by suppressing the nuclear factor-κB signaling pathway. Diabetes, 58: 344-351. doi:10.2337/db07-1795. PMID:19008341.
50. Lessard, S. J., Lo Giudice, S. L., Lau, W., Reid, J. J., Turner, N., Febbraio, M. A., et al. 2004. Rosiglitazone enhances glucose tolerance by mechanisms other than reduction of fatty acid accumulation within skeletal muscle. Endocrinology, 145: 5665-5670. doi:10.1210/en.2004-0659. PMID:15375026.
51. Lipscombe, L. L., Gomes, T., Levesque, L. E., Hux, J. E., Juurlink, D. N., and Alter, D. A. 2007. Thiazolidinediones and cardiovascular outcomes in older patients with diabetes. JAMA, 298: 2634-2643. doi:10.1001/jama.298.22.2634. PMID:18073359.
52. Matsusue, K., Haluzik, M., Lambert, G., Yim, S. H., Gavrilova, O., Ward, J. M., et al. 2003. Liver-specific disruption of PPARγ in leptin-deficient mice improves fatty liver but aggravates diabetic phenotypes. J. Clin. Invest. 111: 737-747. doi:10.1172/JCI17223. PMID:12618528.
53. Matthews, V. B., Allen, T. L., Risis, S., Chan, M. H., Henstridge, D. C., Watson, N., et al. 2010. Interleukin-6-deficient mice develop hepatic inflammation and systemic insulin resistance. Diabetologia, 53: 2431-2341. doi:10.1007/s00125-010-1865-y. PMID:20697689.
54. Mayerson, A. B., Hundal, R. S., Dufour, S., Lebon, V., Befroy, D., Cline, G. W., et al. 2002. The effects of rosiglitazone on insulin sensitivity, lipolysis, and hepatic and skeletal muscle triglyceride content in patients with type 2 diabetes. Diabetes, 51: 797-802. doi:10.2337/diabetes.51.3.797. PMID:11872682.
55. Miyazaki, Y., Glass, L., Triplitt, C., Matsuda, M., Cusi, K., Mahankali, A., et al. 2001a. Effect of rosiglitazone on glucose and non-esterified fatty acid metabolism in type II diabetic patients. Diabetologia, 44: 2210-2219. doi:10.1007/s001250100031. PMID:11793023.
56. Miyazaki, Y., Mahankali, A., Matsuda, M., Glass, L., Mahankali, S., Ferrannini, E., et al. 2001b. Improved glycemic control and enhanced insulin sensitivity in type 2 diabetic subjects treated with pioglitazone. Diabetes Care, 24: 710-719. doi:10.2337/diacare.24.4.710. PMID:11315836.
57. Miyazaki, Y., He, H., Mandarino, L. J., and DeFronzo, R. A. 2003. Rosiglitazone improves downstream insulin receptor signaling in type 2 diabetic patients. Diabetes, 52: 1943-1950. doi:10.2337/diabetes.52.8.1943. PMID:12882909.
58. Mohamed-Ali, V., Goodrick, S., Rawesh, A., Katz, D. R., Miles, J. M., Yudkin, J. S., et al. 1997. Subcutaneous adipose tissue releases interleukin-6, but not tumor necrosis factor-α, in vivo. J. Clin. Endocrinol. Metab. 82: 4196-4200. doi:10.1210/jc.82.12.4196. PMID:9398739.
59. Molero, J. C., Lee, S., Leizerman, I., Chajut, A., Cooper, A., and Walder, K. 2010. Effects of rosiglitazone on intramyocellular lipid accumulation in Psammomys obesus. Biochim. Biophys. Acta, 1802: 235-239. doi:10.1016/j.bbadis.2009.10.002. PMID:19835953.
60. Nawrocki, A. R., Rajala, M. W., Tomas, E., Pajvani, U. B., Saha, A. K., Trumbauer, M. E., et al. 2006. Mice lacking adiponectin show decreased hepatic insulin sensitivity and reduced responsiveness to peroxisome proliferator-activated receptor gamma agonists. J. Biol. Chem. 281: 2654-2660. PMID:16326714.
61. Nichols, G. A., and Gomez-Caminero, A. 2007. Weight changes following the initiation of new anti-hyperglycaemic therapies. Diabetes Obes. Metab. 9: 96-102. doi:10.1111/j.1463-1326.2006.00580.x. PMID:17199724.
62. Nielsen, N. B., Hojbjerre, L., Sonne, M. P., Alibegovic, A. C., Vaag, A., Dela, F., and Stallknecht, B. 2009. Interstitial concentrations of adipokines in subcutaneous abdominal and femoral adipose tissue. Regul. Pept. 155: 39-45. doi:10.1016/j.regpep.2009.04.010. PMID:19376162.
63. Nolan, J. J., Ludvik, B., Beerdsen, P., Joyce, M., and Olefsky, J. 1994. Improvement in glucose tolerance and insulin resistance in obese subjects treated with troglitazone. N. Engl. J. Med. 331: 1188-1193. doi:10.1056/NEJM199411033311803. PMID:7935656.
64. Norris, A. W., Chen, L., Fisher, S. J., Szanto, I., Ristow, M., Jozsi, A. C., et al. 2003. Muscle-specific PPARγ-deficient mice develop increased adiposity and insulin resistance but respond to thiazolidinediones. J. Clin. Invest. 112: 608-618. doi:10.1172/JCI200317305. PMID:12925701.
65. Olswang, Y., Cohen, H., Papo, O., Cassuto, H., Croniger, C. M., Hakimi, P., et al. 2002. A mutation in the peroxisome proliferator-activated receptor gammabinding site in the gene for the cytosolic form of phosphoenolpyruvate carboxykinase reduces adipose tissue size and fat content in mice. Proc. Natl. Acad. Sci. U. S. A. 99: 625-630. doi:10.1073/pnas.022616299. PMID:11792850.
66. O'Neill, H. M., Maarbjerg, S. J., Crane, J. D., Jeppesen, J., Jorgensen, S. B., Schertzer, J. D., et al. 2011. AMP-activated protein kinase (AMPK) β1β2 muscle null mice reveal an essential role for AMPK in maintaining mitochondrial content and glucose uptake during exercise. Proc. Natl. Acad. Sci. U. S. A. 108: 16092-16097. doi:10.1073/pnas.1105062108. PMID:21896769.
67. O'Neill, H. M., Holloway, G. P., and Steinberg, G. R. 2013. AMPK regulation of fatty acid metabolism and mitochondrial biogenesis: implications for obesity. Mol. Cell. Endocrinol. 366 (2): 135-151. doi:10.1016/j.mce.2012.06.019. PMID:22750049.
68. Ostrowski, K., Rohde, T., Zacho, M., Asp, S., and Pedersen, B. K. 1998. Evidence that interleukin-6 is produced in human skeletal muscle during prolonged running. J. Physiol. 508 (3): 949-953. doi:10.1111/j.1469-7793.1998.949bp.x. PMID:9518745.
69. Pedersen, B. K., and Febbraio, M. A. 2008. Muscle as an endocrine organ: focus on muscle-derived interleukin-6. Physiol. Rev. 88: 1379-1406. doi:10.1152/physrev.90100.2007. PMID:18923185.
70. Petrovic, N., Walden, T. B., Shabalina, I. G., Timmons, J. A., Cannon, B., and Nedergaard, J. 2010. Chronic peroxisome proliferator-activated receptor γ (PPARγ) activation of epididymally derived white adipocyte cultures reveals a population of thermogenically competent, UCP1-containing adipocytes molecularly distinct from classic brown adipocytes. J. Biol. Chem. 285: 7153-7164. doi:10.1074/jbc.M109.053942. PMID:20028987.
71. Phillips, L. S., Grunberger, G., Miller, E., Patwardhan, R., Rappaport, E. B., and Salzman, A. 2001. Once-and twice-daily dosing with rosiglitazone improves glycemic control in patients with type 2 diabetes. Diabetes Care, 24: 308-315. doi:10.2337/diacare.24.2.308. PMID:11213884.
72. Picard, F., Kurtev, M., Chung, N., Topark-Ngarm, A., Senawong, T., Machado De Oliveira, R., et al. 2004. Sirt1 promotes fat mobilization in white adipocytes by repressing PPAR-γ. Nature, 429: 771-776. doi:10.1038/nature02583. PMID:15175761.
73. Pillai, J. B., Chen, M., Rajamohan, S. B., Samant, S., Pillai, V. B., Gupta, M., and Gupta, M. P. 2008. Activation of SIRT1, a class III histone deacetylase, contributes to fructose feeding-mediated induction of the α-myosin heavy chain expression. Am. J. Physiol. Heart Circ. Physiol. 294: H1388-H1397. doi:10.1152/ajpheart.01339.2007. PMID:18192211.
74. Poulsen, M. M., Vestergaard, P. F., Clasen, B. F., Radko, Y., Christensen, L. P., Stodkilde-Jorgensen, H., et al. 2013. High-dose resveratrol supplementation in obese men: an investigator-initiated, randomized, placebo-controlled clinical trial of substrate metabolism, insulin sensitivity, and body composition. Diabetes, 62 (4): 1186-1195. doi:10.2337/db12-0975. PMID:23193181.
75. Price, N. L., Gomes, A. P., Ling, A. J., Duarte, F. V., Martin-Montalvo, A., North, B. J., et al. 2012. SIRT1 is required for AMPK activation and the beneficial effects of resveratrol on mitochondrial function. Cell Metab. 15: 675-690. doi:10.1016/j.cmet.2012.04.003. PMID:22560220.
76. Qiang, L., Wang, L., Kon, N., Zhao, W., Lee, S., Zhang, Y., et al. 2012. Brown remodeling of white adipose tissue by SirT1-dependent deacetylation of Pparγ. Cell, 150: 620-632. doi:10.1016/j.cell.2012.06.027. PMID:22863012.
77. Qin, F., Siwik, D. A., Luptak, I., Hou, X., Wang, L., Higuchi, A., et al. 2011. The polyphenols resveratrol and S17834 prevent the structural and functional sequelae of diet-induced metabolic heart disease in mice. Circulation, 125: 1757-1764, S1-S6. doi:10.1161/CIRCULATIONAHA.111.067801. PMID:22388319.
78. Rayalam, S., Yang, J. Y., Ambati, S., Della-Fera, M. A., and Baile, C. A. 2008. Resveratrol induces apoptosis and inhibits adipogenesis in 3T3-L1 adipocytes. Phytother. Res. 22: 1367-1371. doi:10.1002/ptr.2503. PMID:18688788.
79. Reshef, L., Olswang, Y., Cassuto, H., Blum, B., Croniger, C. M., Kalhan, S. C., et al. 2003. Glyceroneogenesis and the triglyceride/fatty acid cycle. J. Biol. Chem. 278: 30413-30416. doi:10.1074/jbc.R300017200. PMID:12788931.
80. Richter, E. A., Garetto, L. P., Goodman, M. N., and Ruderman, N. B. 1984. Enhanced muscle glucose metabolism after exercise: modulation by local factors. Am. J. Physiol. 246: E476-E482. PMID:6430094.
81. Ringholm, S., Grunnet Knudsen, J., Leick, L., Lundgaard, A., Munk Nielsen, M., and Pilegaard, H. 2013. PGC-1α is required for exercise-and exercise traininginduced UCP1 up-regulation in mouse white adipose tissue. PLoS One, 8: e64123. doi:10.1371/journal.pone.0064123. PMID:23717545.
82. Rivera, L., Moron, R., Zarzuelo, A., and Galisteo, M. 2009. Long-term resveratrol administration reduces metabolic disturbances and lowers blood pressure in obese Zucker rats. Biochem. Pharmacol. 77: 1053-1063. doi:10.1016/j.bcp.2008.11.027. PMID:19100718.
83. Rognstad, R., and Katz, J. 1966. The balance of pyridine nucleotides and ATP in adipose tissue. Proc. Natl. Acad. Sci. U. S. A. 55: 1148-1156. doi:10.1073/pnas.55.5.1148. PMID:4381021.
84. Rosen, E. D., and Spiegelman, B. M. 2006. Adipocytes as regulators of energy balance and glucose homeostasis. Nature, 444: 847-853. doi:10.1038/nature05483. PMID:17167472.
85. Rostrup, E., Slettom, G., Seifert, R., Bjorndal, B., Berge, R. K., and Nordrehaug, J. E. 2013. Effect of combined thermal and electrical muscle stimulation on cardiorespiratory fitness and adipose tissue in obese individuals. Eur. J. Prev. Cardiol. In press. doi:10.1177/2047487313483606. PMID:23515446.
86. Ruge, T., Lockton, J. A., Renstrom, F., Lystig, T., Sukonina, V., Svensson, M. K., and Eriksson, J. W. 2009. Acute hyperinsulinemia raises plasma interleukin-6 in both nondiabetic and type 2 diabetes mellitus subjects, and this effect is inversely associated with body mass index. Metabolism, 58: 860-866. doi:10.1016/j.metabol.2009.02.010. PMID:19375766.
87. Ruschke, K., Fishbein, L., Dietrich, A., Kloting, N., Tonjes, A., Oberbach, A., et al. 2010. Gene expression of PPARγ and PGC-1α in human omental and subcutaneous adipose tissues is related to insulin resistance markers and mediates beneficial effects of physical training. Eur. J. Endocrinol. 162: 515-523. doi:10.1530/EJE-09-0767. PMID:19966034.
88. Sopasakis, V. R., Sandqvist, M., Gustafson, B., Hammarstedt, A., Schmelz, M., Yang, X., et al. 2004. High local concentrations and effects on differentiation implicate interleukin-6 as a paracrine regulator. Obes. Res. 12: 454-460. doi:10.1038/oby.2004.51. PMID:15044662.
89. Stallknecht, B., Vinten, J., Ploug, T., and Galbo, H. 1991. Increased activities of mitochondrial enzymes in white adipose tissue in trained rats. Am. J. Physiol. 261: E410-E414. PMID:1653528.
90. Steensberg, A., Febbraio, M. A., Osada, T., Schjerling, P., van Hall, G., Saltin, B., and Pedersen, B. K. 2001. Interleukin-6 production in contracting human skeletal muscle is influenced by pre-exercise muscle glycogen content. J. Physiol. 537: 633-639. doi:10.1111/j.1469-7793.2001.00633.x. PMID:11731593.
91. Suchankova, G., Nelson, L. E., Gerhart-Hines, Z., Kelly, M., Gauthier, M. S., Saha, A. K., et al. 2009. Concurrent regulation of AMP-activated protein kinase and SIRT1 in mammalian cells. Biochem. Biophys. Res. Commun. 378: 836-841. doi:10.1016/j.bbrc.2008.11.130. PMID:19071085.
92. Sugii, S., Olson, P., Sears, D. D., Saberi, M., Atkins, A. R., Barish, G. D., et al. 2009. PPARγ activation in adipocytes is sufficient for systemic insulin sensitization. Proc. Natl. Acad. Sci. U. S. A. 106: 22504-22509. doi:10.1073/pnas.0912487106. PMID:20018750.
93. Sulaiman, M., Matta, M. J., Sunderesan, N. R., Gupta, M. P., Periasamy, M., and Gupta, M. 2010. Resveratrol, an activator of SIRT1, upregulates sarcoplasmic calcium ATPase and improves cardiac function in diabetic cardiomyopathy. Am. J. Physiol. Heart Circ. Physiol. 298: H833-H843. doi:10.1152/ajpheart.00418.2009. PMID:20008278.
94. Sutherland, L. N., Capozzi, L. C., Turchinsky, N. J., Bell, R. C., and Wright, D. C. 2008. Time course of high-fat diet-induced reductions in adipose tissue mitochondrial proteins: potential mechanisms and the relationship to glucose intolerance. Am. J. Physiol. Endocrinol. Metab. 295: E1076-E1083. doi:10.1152/ajpendo.90408.2008. PMID:18780775.
95. Sutherland, L. N., Bomhof, M. R., Capozzi, L. C., Basaraba, S. A., and Wright, D. C. 2009. Exercise and adrenaline increase PGC-1α mRNA expression in rat adipose tissue. J. Physiol. 587: 1607-1617. doi:10.1113/jphysiol.2008.165464. PMID:19221126.
96. Tang, W. H., Francis, G. S., Hoogwerf, B. J., and Young, J. B. 2003. Fluid retention after initiation of thiazolidinedione therapy in diabetic patients with established chronic heart failure. J. Am. Coll. Cardiol. 41: 1394-1398. doi:10.1016/S0735-1097(03)00159-1. PMID:12706937.
97. Tiikkainen, M., Hakkinen, A. M., Korsheninnikova, E., Nyman, T., Makimattila, S., and Yki-Jarvinen, H. 2004. Effects of rosiglitazone and metformin on liver fat content, hepatic insulin resistance, insulin clearance, and gene expression in adipose tissue in patients with type 2 diabetes. Diabetes, 53: 2169-2176. doi:10.2337/diabetes.53.8.2169. PMID:15277403.
98. Timmers, S., Konings, E., Bilet, L., Houtkooper, R. H., van de Weijer, T., Goossens, G. H., et al. 2011. Calorie restriction-like effects of 30 days of resveratrol supplementation on energy metabolism and metabolic profile in obese humans. Cell Metab. 14: 612-622. doi:10.1016/j.cmet.2011.10.002. PMID:22055504.
99. Timmons, J. A., Baar, K., Davidsen, P. K., and Atherton, P. J. 2012. Is irisin a human exercise gene? Nature, 488: E9-E10; discussion, E10-E11. doi:10.1038/nature11364. PMID:22932392.
100. Tomas, E., Tsao, T. S., Saha, A. K., Murrey, H. E., Zhang Cc, C., Itani, S. I., et al. 2002. Enhanced muscle fat oxidation and glucose transport by ACRP30 globular domain: acetyl-CoA carboxylase inhibition and AMP-activated protein kinase activation. Proc. Natl. Acad. Sci. U. S. A. 99: 16309-16313. doi:10.1073/pnas.222657499. PMID:12456889.
101. Tonelli, J., Li, W., Kishore, P., Pajvani, U. B., Kwon, E., Weaver, C., et al. 2004. Mechanisms of early insulin-sensitizing effects of thiazolidinediones in type 2 diabetes. Diabetes, 53: 1621-1629. doi:10.2337/diabetes.53.6.1621. PMID:15161771.
102. Um, J. H., Park, S. J., Kang, H., Yang, S., Foretz, M., McBurney, M. W., et al. 2010. AMP-activated protein kinase-deficient mice are resistant to the metabolic effects of resveratrol. Diabetes, 59: 554-563. doi:10.2337/db09-0482. PMID:19934007.
103. Valerio, A., Cardile, A., Cozzi, V., Bracale, R., Tedesco, L., Pisconti, A., et al. 2006. TNF-α downregulates eNOS expression and mitochondrial biogenesis in fat and muscle of obese rodents. J. Clin. Invest. 116: 2791-2798. doi:10.1172/JCI28570. PMID:16981010.
104. van Hall, G., Steensberg, A., Sacchetti, M., Fischer, C., Keller, C., Schjerling, P., et al. 2003. Interleukin-6 stimulates lipolysis and fat oxidation in humans. J. Clin. Endocrinol. Metab. 88: 3005-3010. doi:10.1210/jc.2002-021687. PMID:12843134.
105. Wan, Z., Thrush, A. B., Legare, M., Frier, B. C., Sutherland, L. N., Williams, D. B., and Wright, D. C. 2010. Epinephrine-mediated regulation of PDK4 mRNA in rat adipose tissue. Am. J. Physiol. Cell Physiol. 299: C1162-C1170. doi:10.1152/ajpcell.00188.2010. PMID:20739620.
106. Wan, Z., Frier, B. C., Williams, D. B., and Wright, D. C. 2012a. Epinephrine induces PDK4 mRNA expression in adipose tissue from obese, insulin resistant rats. Obesity (Silver Spring), 20: 453-456. doi:10.1038/oby.2011.252. PMID:21818153.
107. Wan, Z., Perry, C. G., Macdonald, T., Chan, C. B., Holloway, G. P., and Wright, D. C. 2012b. IL-6 is not necessary for the regulation of adipose tissue mitochondrial content. PLoS One, 7: e51233. doi:10.1371/journal.pone.0051233. PMID:23240005.
108. Wan, Z., Ritchie, I., Beaudoin, M. S., Castellani, L., Chan, C. B., and Wright, D. C. 2012c. IL-6 Indirectly modulates the induction of glyceroneogenic enzymes in adipose tissue during exercise. PLoS One, 7: e41719. doi:10.1371/journal.pone.0041719. PMID:22844518.
109. Wang, T., Zang, Y., Ling, W., Corkey, B. E., and Guo, W. 2003. Metabolic partitioning of endogenous fatty acid in adipocytes. Obes. Res. 11: 880-887. doi:10.1038/oby.2003.121. PMID:12855758.
110. Wilson-Fritch, L., Burkart, A., Bell, G., Mendelson, K., Leszyk, J., Nicoloro, S., et al. 2003. Mitochondrial biogenesis and remodeling during adipogenesis and in response to the insulin sensitizer rosiglitazone. Mol. Cell. Biol. 23: 1085-1094. doi:10.1128/MCB.23.3.1085-1094.2003. PMID:12529412.
111. Wilson-Fritch, L., Nicoloro, S., Chouinard, M., Lazar, M. A., Chui, P. C., Leszyk, J., et al. 2004. Mitochondrial remodeling in adipose tissue associated with obesity and treatment with rosiglitazone. J. Clin. Invest. 114: 1281-1289. doi:10.1172/JCI200421752. PMID:15520860.
112. Xu, X., Ying, Z., Cai, M., Xu, Z., Li, Y., Jiang, S. Y., et al. 2011. Exercise ameliorates high-fat diet-induced metabolic and vascular dysfunction, and increases adipocyte progenitor cell population in brown adipose tissue. Am. J. Physiol. Regul. Integr. Comp. Physiol. 300: R1115-R1125. doi:10.1152/ajpregu.00806.2010. PMID:21368268.
113. Yamauchi, T., Kamon, J., Waki, H., Murakami, K., Motojima, K., Komeda, K., et al. 2001a. The mechanisms by which both heterozygous peroxisome proliferator-activated receptor γ (PPARγ) deficiency and PPARγ agonist improve insulin resistance. J. Biol. Chem. 276: 41245-41254. doi:10.1074/jbc.M103241200. PMID:11533050.
114. Yamauchi, T., Kamon, J., Waki, H., Terauchi, Y., Kubota, N., Hara, K., et al. 2001b. The fat-derived hormone adiponectin reverses insulin resistance associated with both lipoatrophy and obesity. Nat. Med. 7: 941-946. doi:10.1038/90984. PMID:11479627.
115. Yamauchi, T., Kamon, J., Minokoshi, Y., Ito, Y., Waki, H., Uchida, S., et al. 2002. Adiponectin stimulates glucose utilization and fatty-acid oxidation by activating AMP-activated protein kinase. Nat. Med. 8: 1288-1295. doi:10.1038/nm788. PMID:12368907.
116. Yeung, F., Hoberg, J. E., Ramsey, C. S., Keller, M. D., Jones, D. R., Frye, R. A., and Mayo, M. W. 2004. Modulation of NF-κB-dependent transcription and cell survivalbythe SIRT1 deacetylase. EMBOJ. 23: 2369-2380. doi:10.1038/sj.emboj.7600244. PMID:15152190.
117. Yoon, U., Kwok, L. L., and Magkidis, A. 2013. Efficacy of lifestyle interventions in reducing diabetes incidence in patients with impaired glucose tolerance: a systematic review of randomized controlled trials. Metabolism, 62: 303-314. doi:10.1016/j.metabol.2012.07.009. PMID:22959500.
118. Yoshino, J., Conte, C., Fontana, L., Mittendorfer, B., Imai, S., Schechtman, K. B., et al. 2012. Resveratrol supplementation does not improve metabolic function in nonobese women with normal glucose tolerance. Cell Metab. 16: 658-664. doi:10.1016/j.cmet.2012.09.015. PMID:23102619.
119. Zang, M., Xu, S., Maitland-Toolan, K. A., Zuccollo, A., Hou, X., Jiang, B., et al. 2006. Polyphenols stimulate AMP-activated protein kinase, lower lipids, and inhibit accelerated atherosclerosis in diabetic LDL receptor-deficient mice. Diabetes, 55: 2180-2191. doi:10.2337/db05-1188. PMID:16873680.
120. Zhang, J., Chen, L., Zheng, J., Zeng, T., Li, H., Xiao, H., Deng, X., and Hu, X. 2012. The protective effect of resveratrol on islet insulin secretion and morphology in mice on a high-fat diet. Diabetes Res. Clin. Pract. 97: 474-482. doi:10.1016/j.diabres.2012.02.029. PMID:22497970.
121. Zimmermann, R., Strauss, J. G., Haemmerle, G., Schoiswohl, G., Birner-Gruenberger, R., Riederer, M., et al. 2004. Fat mobilization in adipose tissue is promoted by adipose triglyceride lipase. Science, 306: 1383-1386. doi:10.1126/science.1100747. PMID:15550674.